The move to allow kids ages 12-15 to get the shot could be a game-changer for getting students back into the classroom.
The Food and Drug Administration on Monday granted Pfizer’s request to expand the use of its COVID-19 vaccine to adolescents ages 12-15.
“Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic,” acting FDA Commissioner Janet Woodcock said in a statement. “Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations.”
Shots could be administered after a Centers for Disease Control and Prevention advisory committee meets Wednesday to issue recommendations on the use of the vaccine in the age bracket.
The move could be a game-changer for getting students back into the classroom, as some parents have expressed interest in vaccinating their children before resuming in-person schooling. Middle and high schools have particularly struggled with physical reopenings because it is more difficult to cohort students and staff into groups that stay together throughout the day.
It also opens up vaccines to millions of children, which experts believe is an important step for increasing immunity in the population.
Pfizer announced last month that it submitted a request to the FDA to expand its coronavirus vaccine emergency use authorization to the age bracket after it reported that trial results of kids aged 12-15 “demonstrated 100% efficacy and robust antibody responses, exceeding those recorded earlier in vaccinated participants aged 16 to 25 years old, and was well tolerated.”
The vaccine developed by Pfizer and German company BioNTech was previously authorized for emergency use in individuals ages 16 and older. Coronavirus vaccines from Moderna and Johnson & Johnson have been authorized for such use in those 18 and older.
Pfizer last week filed for full regulatory approval for its vaccine from the FDA. The company also said it expects to submit a request in September to the FDA to expand its vaccine use to children ages 2-11.
According to usnews.com. Source of photos: internet